Technology transfer for Parkinson’s

Partnership objective

Transfer of scientific knowledge and technology to improve access to treatment for Parkinson’s Disease in Brazil.

This private-public partnership was set up in order to transfer the technology used in the treatment of Parkinson’s disease to Brazil. This private-public partnership was set up in order to transfer the technology used in the treatment of Parkinson’s disease to Brazil. Copyright Photo credits: Boehringer Ingelheim

Description of partnership activities and how they address needs and challenges

This private-public partnership (PPP) was set up between Boehringer Ingelheim and the Ministry of Health of Brazil in order to transfer the technology used in the treatment of Parkinson’s disease, pramipexole immediate-release. This is with a view to reducing the cost of treatment and speeding up drug access for patients. The collaboration agreement also aims to put the government in the position to reduce the country’s dependence on imported drugs. 

Partnership information

Company(ies) Boehringer Ingelheim

Partner(s) Brazilian Ministry of Health

Type of Partner(s) Government

Therapeutic Focus Mental and Neurological Disorders

Disease(s) Dementia

Program Type(s) Availability of Treatment - Technology Transfer - Manufacturing and Entrepreneurial Know-How

Targeted Population(s) Elderly

Region(s) Latin America & Caribbean

Number of Countries 1

Country(ies) Brazil

Start Date 2011

More information For Better Health Brochure

Anticipated completion date Ongoing